cllsociety.org

Webbplats analys cllsociety.org

CLL Society, the Leading Authority for CLL and SLL Patients

 Genereras på Mars 20 2026 07:16 AM

Gammal statistik? UPDATERA !

Ställningen är 54/100

SEO Innehåll

Titel

CLL Society, the Leading Authority for CLL and SLL Patients

Längd : 59

Perfekt, din titel innehåller mellan 10 och 70 tecken.

Beskrivning

CLL Society is devoted to serving chronic lymphocytic leukemia and small lymphocytic lymphoma cancer patients and caregivers through support and education.

Längd : 155

Bra, din metabeskrivning innehåller mellan 70 och 160 tecken.

Nyckelord

Mycket dåligt. Vi har inte lyckats hitta några meta-taggar på din sida. Använd denna meta-tag generator, gratis för att skapa nyckelord.

Og Meta Egenskaper

Bra, din sida drar nytta utav Og.

Egendom Innehåll
locale en_US
type website
title Get the Best Care for Your Chronic Lymphocytic Leukemia - CLL Society
description Addressing the unmet needs of the Chronic Lymphocytic Leukemia (CLL) community, our goal is to provide recent and relevant information for CLL patients.
url https://cllsociety.org/
site_name CLL Society
image https://cllsociety.org/wp-content/uploads/2022/04/CLL-Society-LOGO-w_Tag_Neon_Letter_cropped-300x226-1.png
image:width 300
image:height 226
image:type image/png

Rubriker

H1 H2 H3 H4 H5 H6
2 12 6 3 5 0
  • [H1] Meet our new research grantees
  • [H1] WELCOME
  • [H2] Actively Enrolling Clinical Trials in CLL
  • [H2] Support Our Work
  • [H2] Fast Find
  • [H2] Newly Diagnosed
  • [H2] Testing & Imaging
  • [H2] Treatment & Research
  • [H2] Medicine Cabinet
  • [H2] Support Groups
  • [H2] Free CLL Expert Opinion
  • [H2] Normal Lab Values & Tracker
  • [H2] Ask the Experts
  • [H2] What’s New in CLL / SLL?
  • [H3] From Diagnosis to Advocacy: Albie Suozzi’s CLL Journey Featured on the Cover of Cancer Health
  • [H3] Meet a New More Dangerous Doctor than Dr. Google: AI
  • [H3] Golf, 25 Years of CLL, and Long Remissions
  • [H3] CLL Patients are Immunocompromised, But What Does That Mean?
  • [H3] FDA Approves Combo of Acalabrutinib and Venetoclax in CLL
  • [H3] Epcoritamab Combination Therapies for Richter Transformation
  • [H4] LIVING WITH CLL
  • [H4] TREATMENT & RESEARCH
  • [H4] Privacy Overview
  • [H5] An investigational CAR-T option
  • [H5] Simplify Initiation, Discover More
  • [H5] A clinical study for BTK inhibitors resistance
  • [H5] A Study of an Investigational Agent in Mature B-Cell Malignancies
  • [H5] A Study of an Investigational Agent That Uses a Risk-Guided Approach for Relapsed CLL / SLL

Bilder

Vi hittade 30 bilder på denna webbsida.

19 alt attribut är tomma eller saknas. Lägg till alternativ text så att sökmotorer enklare kan förstå innehållet i dina bilder.

Text/HTML Ratio

Ratio : 4%

Denna sidas förhållande mellan text till HTML-kod är lägre än 15 procent, vilket innebär att din webbplats troligen behöver mer textinnehåll.

Flash

Perfekt, inga Flash-innehåll har upptäckts på denna sida.

Iframe

Synd, du har Iframes på webbsidorna vilket innebär att innehållet i en Iframe inte kan indexeras.

URL Rewrite

Bra. Dina adressfält ser bra ut!

Understreck i URLen

Vi har upptäckt understreck i din webbadress. Du bör hellre använda bindestreck för att optimera din SEO.

In-page länkar

Vi hittade totalt 104 länkar inklusive 1 länk(ar) till filer

Anchor Typ Juice
Skip to content Interna Passing Juice
HOME Interna Passing Juice
What’s New Interna Passing Juice
Info & Mgmt Interna Passing Juice
Newly Diagnosed Interna Passing Juice
CLL / SLL Patient Education Toolkit Interna Passing Juice
Watch and Wait Interna Passing Juice
Build Your Care Team Interna Passing Juice
CLL Doctors Interna Passing Juice
CLL / SLL Symptoms Interna Passing Juice
Basic Biology of CLL Interna Passing Juice
Staging Interna Passing Juice
Complications Interna Passing Juice
CLL Testing & Imaging Interna Passing Juice
CLL Diagnosis Interna Passing Juice
Test Before Treat™ Interna Passing Juice
Treatment and Research Interna Passing Juice
Indications for Treatment Interna Passing Juice
CLL Medicine Cabinet Interna Passing Juice
Clinical Trials Interna Passing Juice
Clinical Trial Basics Interna Passing Juice
Opening Trials & Status Updates Interna Passing Juice
Clinical Trial Results Interna Passing Juice
The Patient Perspective Interna Passing Juice
Targeted Therapies Interna Passing Juice
Immunotherapy Interna Passing Juice
Chemotherapy Interna Passing Juice
CAR-T and Other Cellular Therapies Interna Passing Juice
Frontline Therapies Interna Passing Juice
Relapsed/Refractory or Later Therapies Interna Passing Juice
Richter’s Transformation Interna Passing Juice
MRD and Disease Monitoring Interna Passing Juice
CLL / SLL Resources Interna Passing Juice
Normal CLL Lab Values Interna Passing Juice
Keeping Track of Lab Results Interna Passing Juice
CLL Glossary Interna Passing Juice
CLL Abbreviations & Acronyms Interna Passing Juice
Ask the Experts Interna Passing Juice
Health Equity in CLL Interna Passing Juice
Opinions and Insights Interna Passing Juice
Regulatory News Interna Passing Juice
Programs & Support Interna Passing Juice
Support Groups Interna Passing Juice
1-on-1 Support Programs Interna Passing Juice
Upcoming Events Interna Passing Juice
Expert Access™ Interna Passing Juice
Education On-Demand Interna Passing Juice
CareCast Podcast Interna Passing Juice
COVID-19 Interna Passing Juice
COVID-19 Action Plan Interna Passing Juice
COVID-19 Updates Interna Passing Juice
COVID-19 Prevention & Treatment Interna Passing Juice
COVID-19 Official Statements Interna Passing Juice
COVID-19 Virtual Community Meetings Interna Passing Juice
COVID-19 General Information Interna Passing Juice
Living With CLL Interna Passing Juice
Stories and Testimonials Interna Passing Juice
Financial Resources Interna Passing Juice
Insurance Resources Interna Passing Juice
Mental and Physical Health Interna Passing Juice
Dr. Koffman’s Blogs Interna Passing Juice
Creative Corner Interna Passing Juice
Being Your Own Advocate Interna Passing Juice
Care Partners Interna Passing Juice
Veterans Interna Passing Juice
End of Life Planning Interna Passing Juice
Surveys Interna Passing Juice
About Us Interna Passing Juice
CLL Society in the News Interna Passing Juice
Our Story, Mission, and Vision Interna Passing Juice
Scientific Publications Interna Passing Juice
Board of Directors Interna Passing Juice
Medical Advisory Board Interna Passing Juice
Expert Medical Council Interna Passing Juice
International Partners Interna Passing Juice
Special Contributors Interna Passing Juice
Patient Advisory Board Interna Passing Juice
CLL Society Staff Interna Passing Juice
Volunteers Interna Passing Juice
Contact Us Interna Passing Juice
CLL Society Industry Advisory Council Interna Passing Juice
Research Interna Passing Juice
Current Funding Opportunities Interna Passing Juice
Apply for a Grant Interna Passing Juice
Eligibility Interna Passing Juice
Selection and Review Process Interna Passing Juice
Research Program Guidelines Interna Passing Juice
What We Fund Interna Passing Juice
Support Our Efforts Interna Passing Juice
Advocacy Interna Passing Juice
Needs of the Immunocompromised Interna Passing Juice
Access Interna Passing Juice
Innovation Interna Passing Juice
Donate Interna Passing Juice
Community Fundraising Interna Passing Juice
Celebrating Long Lives 5K Event Externa Passing Juice
Legacy Giving Interna Passing Juice
From Diagnosis to Advocacy: Albie Suozzi’s CLL Journey Featured on the Cover of Cancer Health Interna Passing Juice
Meet a New More Dangerous Doctor than Dr. Google: AI Interna Passing Juice
Golf, 25 Years of CLL, and Long Remissions Interna Passing Juice
CLL Patients are Immunocompromised, But What Does That Mean? Interna Passing Juice
FDA Approves Combo of Acalabrutinib and Venetoclax in CLL Interna Passing Juice
Epcoritamab Combination Therapies for Richter Transformation Interna Passing Juice
Site Design Externa Passing Juice

SEO Nyckelord

Nyckelord Moln

cll covid-19 cookies sll clinical resources support research cookie treatment

Nyckelord Konsistens

Nyckelord Innehåll Titel Nyckelord Beskrivning Rubriker
cll 106
covid-19 28
cookies 24
sll 22
research 22

Användbarhet

Url

Domän : cllsociety.org

Längd : 14

Favikon

Bra, din webbplats har en favicon.

Utskriftbart

Vi kunde inte hitta CSS för utskrifter.

Språk

Bra. Ditt angivna språk är en.

Dublin Core

Denna sida drar inte nytta utav Dublin Core.

Dokument

Doctype

HTML 5

Encoding

Perfekt. Din deklarerade teckenuppsättning är UTF-8.

W3C Validity

Errors : 0

Varningar : 0

E-post Sekretess

Bra! Ingen e-postadress har hittats i klartext.

Föråldrad HTML

Bra! Vi har inte hittat några föråldrad HTML taggar i din HTML.

Hastighets Tips

Utmärkt, din webbplats använder inga nästlade tabeller.
Synd, din webbplats använder sig utav inline stilar.
Bra, din webbplats har få CSS-filer.
Synd, din webbplats har för många JS filer (fler än 6 stycken).
Perfekt, din webbplats utnyttjar gzip.

Mobil

Mobiloptimering

Apple Ikon
Meta Viewport Tagg
Flash innehåll

Optimering

XML Sitemap

Bra, din webbplats har en XML sitemap.

https://cllsociety.org/sitemap_index.xml

Robots.txt

https://cllsociety.org/robots.txt

Bra, din webbplats har en robots.txt fil.

Analytics

Bra, din webbplats har ett analysverktyg.

   Google Analytics

PageSpeed Insights


Enhet
Kategorier

Free SEO Testing Tool

Free SEO Testing Tool är en fri SEO verktyg som hjälper dig att analysera din webbplats